Leprosy: what is new

Avneet Randhawa1, Rajendra Kapila1, Robert A Schwartz1

  • 1Rutgers University New Jersey Medical School, New Jersey Medical School, Newark, NJ, USA.

Insights

Leprosy (Hansen's disease) research highlights new insights into its causes, including Mycobacterium lepromatosis and zoonotic transmission. Advances include the LepVax vaccine and understanding genetic susceptibility factors.

Area of Science:

  • Infectious Diseases
  • Genetics
  • Immunology

Background:

  • Leprosy, or Hansen's disease, is a chronic granulomatous infection with significant cutaneous and neurologic manifestations.
  • Historically attributed to Mycobacterium leprae, a second species, Mycobacterium lepromatosis, was identified in 2008.
  • The current BCG vaccine's efficacy is variable, prompting the development of novel interventions.

Purpose of the Study:

  • To provide an updated overview of leprosy research.
  • To discuss emerging etiological factors, transmission routes, and genetic predispositions.
  • To explore the impact of coinfections and advancements in therapeutic strategies.

Main Methods:

  • Review of recent scientific literature on leprosy.
  • Analysis of new findings regarding causative agents and transmission.
  • Examination of genetic studies and vaccine development progress.

Main Results:

  • Identification of Mycobacterium lepromatosis as an additional causative agent.
  • Emerging evidence for zoonotic transmission from armadillos and Eurasian red squirrels.
  • Discovery of genetic polymorphisms, like MRPS5, influencing leprosy susceptibility.
  • Advancement of the LepVax subunit vaccine into human trials.
  • Investigation into leprosy coinfections with COVID-19, HIV, and HTLV-1.

Conclusions:

  • Leprosy research is rapidly evolving with new causative agents and transmission pathways.
  • Genetic insights and novel vaccines like LepVax offer promising future directions.
  • Understanding coinfections and updated treatment regimens are crucial for managing leprosy.

Related Concept Videos

Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.6K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
511
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
619
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
393
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
227
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
264